3-Butoxy-2,6-difluorobenzoic acid
- $199 - $562
- Product name: 3-Butoxy-2,6-difluorobenzoic acid
- CAS: 1706434-98-1
- MF: C11H12F2O3
- MW: 230.21
- EINECS:
- MDL Number:MFCD27986833
- Synonyms:3-Butoxy-2,6-difluorobenzoic acid;Benzoic acid, 3-butoxy-2,6-difluoro-
5 prices
Selected condition:
Brand
- Alichem
- Crysdot
- Matrix Scientific
- SynQuest Laboratories
Package
- 1g
- 5g
- 10g
- ManufacturerAlichem
- Product number1706434981
- Product description3-Butoxy-2,6-difluorobenzoicacid
- Packaging1g
- Price$562
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12134028
- Product description3-Butoxy-2,6-difluorobenzoicacid 97%
- Packaging1g
- Price$556
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number117868
- Product description3-Butoxy-2,6-difluorobenzoic acid
- Packaging5g
- Price$294
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number117868
- Product description3-Butoxy-2,6-difluorobenzoic acid
- Packaging10g
- Price$515
- Updated2021-12-16
- Buy
- ManufacturerSynQuest Laboratories
- Product number2621-3-3T
- Product description3-Butoxy-2,6-difluorobenzoic acid
- Packaging5G
- Price$199
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Alichem | 1706434981 | 3-Butoxy-2,6-difluorobenzoicacid | 1g | $562 | 2021-12-16 | Buy |
Crysdot | CD12134028 | 3-Butoxy-2,6-difluorobenzoicacid 97% | 1g | $556 | 2021-12-16 | Buy |
Matrix Scientific | 117868 | 3-Butoxy-2,6-difluorobenzoic acid | 5g | $294 | 2021-12-16 | Buy |
Matrix Scientific | 117868 | 3-Butoxy-2,6-difluorobenzoic acid | 10g | $515 | 2021-12-16 | Buy |
SynQuest Laboratories | 2621-3-3T | 3-Butoxy-2,6-difluorobenzoic acid | 5G | $199 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||
Precautionary statements: |
|